نتائج البحث 1501-1510 من 13464 لعملية البحث عن anti-TNF drugs
The purpose of this study is to compare the PFS of a standard chemotherapy approach versus an IO therapy approach (brentuximab vedotin and nivolumab) in ...
PARP inhibitors are a type of targeted therapy. Adding abemaciclib to olaparib may work better to treat recurrent platinum-resistant ovarian cancer.
Antioxidants (Basel). 2019; doi:10.3390/antiox8080302. Artichoke. Natural Medicines. https://naturalmedicines.therapeuticresearch.com. Accessed Feb. 14, 2024.
This clinical trial evaluates the safety and feasibility of tumor treating fields (TTF) in the treatment of spinal leptomeningeal disease in patients with ...
Terence T. Sio, M.D., M.S.. Oncologist; Radiation Oncologist. Phoenix, AZ. مناطق التركيز: Radiation therapy, Brain stereotactic radiosurgery, Proton ...
... anti-PD1) vs investigator choice (including clinical trials of investigational agents, salvage therapy per local standard of care (SoC), best supportive ...
... therapy. This protocol will also provide a vehicle for CSF access for patients or providers wishing to generate or evaluate individualized biomarkers as ...
... treatment until disease progression or 2 years since treatment ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... Anti-PD-1/L1 in ...
Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...
Pituitary tumor registry. Rochester, Minn. The purpose of this data registry involves the collection of standard of care clinical treatment regimens, diagnostic ...
لا تُقدم Mayo Clinic الدعم للشركات أو المنتجات المُعلَّن عنها هنا. لكن تدعم العائدات الإعلانية رسالتنا غير الربحية.
تحقق من هذه الكتب الأكثر مبيعًا والعروض الخاصة على الكتب والنشرات الإخبارية من Mayo Clinic Press.
تساهم التبرّعات، وهي قابلة للخصم الضريبي، في دعم آخر التطورات في الأبحاث وطرق الرعاية لإحداث نقلة نوعية في الطب.